Collegium Pharmaceutical, Inc.
COLL
$28.23
$0.080.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.29% | -5.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.29% | -5.81% | |||
| Cost of Revenue | 2.00% | -3.69% | |||
| Gross Profit | 3.44% | -6.05% | |||
| SG&A Expenses | 20.92% | 29.53% | |||
| Depreciation & Amortization | 13.48% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.96% | 13.14% | |||
| Operating Income | -63.44% | -49.94% | |||
| Income Before Tax | -172.21% | -35.46% | |||
| Income Tax Expenses | -64.21% | -64.85% | |||
| Earnings from Continuing Operations | -203.83% | -14.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -203.83% | -14.54% | |||
| EBIT | -63.44% | -49.94% | |||
| EBITDA | -12.40% | -26.48% | |||
| EPS Basic | -202.63% | -15.69% | |||
| Normalized Basic EPS | -131.29% | -59.80% | |||
| EPS Diluted | -1,339.84% | -91.87% | |||
| Normalized Diluted EPS | -139.07% | -59.24% | |||
| Average Basic Shares Outstanding | 1.16% | 1.37% | |||
| Average Diluted Shares Outstanding | -18.98% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||